Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas-Reference-Cited by-同舟云学术

Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas

Published:2015-12-01 Issue:7 Volume:68 Page:1079-1089
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Kwon Dohee¹,Kim Sehui¹,Kim Pil-Jong²,Go Heounjeong³,Nam Soo Jeong⁴⁵,Paik Jin Ho⁶,Kim Young A⁷,Kim Tae Min⁸,Heo Dae Seog⁸,Kim Chul Woo¹⁵⁹,Jeon Yoon Kyung¹⁵⁹

Affiliation:

1. Department of Pathology; Seoul National University Hospital; Seoul National University College of Medicine; Seoul South Korea

2. Biomedical Knowledge Engineering Laboratory; Seoul National University School of Dentistry; Seoul South Korea

3. Department of Pathology; Asan Medical Center; University of Ulsan College of Medicine; Seoul South Korea

4. Department of Pathology; Korea Cancer Center Hospital; Seoul South Korea

5. The Tumor Immunity Medical Research Center; Seoul National University College of Medicine; Seoul South Korea

6. Department of Pathology; Seoul National University Bundang Hospital; Seongnam-si South Korea

7. Department of Pathology; Seoul Metropolitan Government Boramae Hospital; Seoul South Korea

8. Department of Internal Medicine; Seoul National University Hospital; Seoul National University College of Medicine; Seoul South Korea

9. Tumor Microenvironment Global Core Research Center; Seoul National University; Seoul South Korea

Funder

Ministry of Education, Science and Technology

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12882/fullpdf

Reference35 articles.

1. Molecular pathogenesis of diffuse large B-cell lymphoma;Schneider;Semin. Diagn. Pathol.,2011

2. Relapsed/refractory diffuse large B-cell lymphoma;Friedberg;Hematology Am. Soc. Hematol. Educ. Program,2011

3. PD-1 and its ligands in tolerance and immunity;Keir;Annu. Rev. Immunol.,2008

4. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas;Frontiers in Oncology;2024-07-18

2. Is There an Immunohistochemical PD-L1 Cut-Off Point That Serves as a Prognostic Indicator for Large B-Cell Lymphomas?;Diagnostics;2024-05-31

3. Frequent expression of PD-L1 in BLS-type diffuse large B-cell lymphoma: implications for aggressiveness and immunotherapy;Pathology;2024-04

4. Correlation between PD-1 and sPD-L1 expression levels in peripheral blood of DLBCL patients and their clinicopathological characteristics;Cellular and Molecular Biology;2024-02-29

5. The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified;Radiology and Oncology;2024-02-21